Regulatory Update

| 01 November 2010

In this Issue
  • FDA Issues Draft Guidance for When an IND Is Required
  • Live Biotherapeutic Products Clinical Trial Guidance Available
  • EMA Becomes More Transparent Regarding Document Access and Conflicts of Interest

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy